These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18648338)

  • 21. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB.
    Stavri H; Ene L; Popa GL; Duiculescu D; Murgoci G; Marica C; Ulea I; Cus G; Popa MI
    Roum Arch Microbiol Immunol; 2009; 68(1):14-9. PubMed ID: 19507622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.
    Sanduzzi A; Bocchino M; Atteno M; Costa L; Ponticiello A; Matarese A; Spanò A; Bruner V; Peluso R; Aquino MM; Del Puente A; Scarpa R
    J Rheumatol Suppl; 2012 Jul; 89():82-5. PubMed ID: 22751601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of repeat tuberculin skin testing in international adoptees: conversions or boosting.
    Mandalakas AM; Kirchner HL; Zhu X; Yeo KT; Starke JR
    Pediatr Infect Dis J; 2008 Oct; 27(10):913-9. PubMed ID: 18776820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population.
    Kariminia A; Sharifnia Z; Aghakhani A; Banifazl M; Eslamifar A; Hazrati M; Ramezani A
    J Eval Clin Pract; 2009 Feb; 15(1):148-51. PubMed ID: 19239595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New diagnostic test for tuberculosis].
    Ravn P; Rose MV; Søborg B; Andersen AB
    Ugeskr Laeger; 2009 Sep; 171(37):2635-9. PubMed ID: 19758506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma release assays and TB diagnosis.
    Drug Ther Bull; 2009 Jun; 47(6):67-70. PubMed ID: 19494343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interferon-gamma release assays in healthcare workers.
    Swindells JE; Aliyu SH; Enoch DA; Abubakar I
    J Hosp Infect; 2009 Oct; 73(2):101-8. PubMed ID: 19699551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
    Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
    J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children.
    Chan PC; Chang LY; Wu YC; Lu CY; Kuo HS; Lee CY; Huang LM; Chen CJ
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1401-6. PubMed ID: 19017449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research agenda of interferon-gamma release assays].
    Higuchi K; Harada N
    Kekkaku; 2009 Apr; 84(4):173-86. PubMed ID: 19425393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.
    Kim HJ; Chung DH; Kim MJ; Jang JH; Kim YW; Han SK; Shim YS; Yim JJ
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1071-6. PubMed ID: 18713507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and management of latent tuberculosis infection.
    Hauck FR; Neese BH; Panchal AS; El-Amin W
    Am Fam Physician; 2009 May; 79(10):879-86. PubMed ID: 19496388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay.
    Harada N; Higuchi K; Mori T
    Jpn J Infect Dis; 2008 Sep; 61(5):415-8. PubMed ID: 18806358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent tuberculosis infection amongst new recruits to the Chinese army: comparison of ELISPOT assay and tuberculin skin test.
    Wu X; Li Q; Yang Y; Zhang C; Li J; Zhang J; Liang Y; Cheng H; Zhang J; Zhu L; Zhang G; Wang L
    Clin Chim Acta; 2009 Jul; 405(1-2):110-3. PubMed ID: 19410567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1464. PubMed ID: 18609725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.